HUDSON RCI ADDIPAK UNIT DOSE VIAL, 0.9% FULL NORMAL SALINE SOLUTION, 3ML;5ML;15ML

Nebulizer (direct Patient Interface)

Teleflex Medical, Inc.

The following data is part of a premarket notification filed by Teleflex Medical, Inc. with the FDA for Hudson Rci Addipak Unit Dose Vial, 0.9% Full Normal Saline Solution, 3ml;5ml;15ml.

Pre-market Notification Details

Device IDK142153
510k NumberK142153
Device Name:HUDSON RCI ADDIPAK UNIT DOSE VIAL, 0.9% FULL NORMAL SALINE SOLUTION, 3ML;5ML;15ML
ClassificationNebulizer (direct Patient Interface)
Applicant Teleflex Medical, Inc. 2917 WECK DR. Research Triangle Park,  NC  27709
ContactJames A Cochie
CorrespondentJames A Cochie
Teleflex Medical, Inc. 2917 WECK DR. Research Triangle Park,  NC  27709
Product CodeCAF  
CFR Regulation Number868.5630 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2014-08-06
Decision Date2015-04-29
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
24026704597424 K142153 000
44026704628146 K142153 000
34026704717812 K142153 000
30197344008128 K142153 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.